Literature DB >> 2919620

Human immunodeficiency virus type 1 in a seronegative patient with visceral Kaposi's sarcoma and hypogammaglobulinemia.

D D Ho1, T Moudgil, H S Robin, M Alam, B J Wallace, Y Mizrachi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2919620     DOI： 10.1016/0002-9343(89)90313-6

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  5 in total

1.  Antiviral antibodies are necessary for control of simian immunodeficiency virus replication.

Authors:  Christopher J Miller; Meritxell Genescà; Kristina Abel; David Montefiori; Donald Forthal; Kristen Bost; Jun Li; David Favre; Joseph M McCune
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

2.  High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.

Authors:  E S Daar; X L Li; T Moudgil; D D Ho
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  Human cytomegalovirus infection is not increased in common variable immunodeficiency.

Authors:  C G Mullighan; S J Read; A G Bird; J B Kurtz; H M Chapel; K I Welsh
Journal:  J Clin Immunol       Date:  1996-09       Impact factor: 8.317

4.  Lymphotropic viruses in 'common variable' immunodeficiency--PCR analysis of lymphocyte DNA for HIV-1 and HHV-6.

Authors:  A Sa'Adu; B J Thomson; L Bountiff; A D Webster
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

5.  CD4-independent, productive infection of a neuronal cell line by human immunodeficiency virus type 1.

Authors:  X L Li; T Moudgil; H V Vinters; D D Ho
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.